A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension
Status:
Completed
Trial end date:
2019-06-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of administration of azilsartan in
pediatric patients aged 6 to less than 16 years with hypertension.